Skip to main content
Scholar Rock Holding Corp logo

Scholar Rock Holding Corp — Investor Relations & Filings

Ticker · SRRK ISIN · US80706P1030 LEI · 549300Z1FLPGL4OWJ459 US Professional, scientific and technical activities
Open in API
Filings indexed 605 across all filing types
Latest filing 2026-06-04 Declaration of Voting R…
Country US United States of America
Listing US SRRK

About Scholar Rock Holding Corp

https://scholarrock.com/

Scholar Rock Holding Corp. is a late-stage biopharmaceutical company that discovers, develops, and delivers therapies for serious diseases, with a focus on neuromuscular disorders. The company's scientific approach is centered on selectively targeting protein growth factors in their latent, inactive state. This proprietary platform aims to modulate biological functions with high specificity, representing a novel method compared to traditional approaches that target already activated proteins. Founded on pioneering research from Harvard Medical School and Boston Children's Hospital, Scholar Rock is developing a new class of medicines to address the underlying causes of disease.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 96% confidence The document is a Form 8-K Current Report filed under Item 5.07 describing the submission of matters to a vote of security holders at the annual meeting, including detailed voting results for director elections, ratification of auditors, and executive compensation. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-06-04 English
10-Q - Scholar Rock Holding Corp (0001727196) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-07 English
8-K - Scholar Rock Holding Corp (0001727196) (Filer)
Regulatory Filings Classification · 85% confidence The document is a U.S. SEC Form 8-K Current Report filing, containing Items 2.02 (Results of Operations and Financial Condition) and 7.01 (Regulation FD Disclosure). It furnishes a press release and corporate presentation as Exhibit 99.1 and 99.2. This is a regulatory compliance submission, not the standalone earnings release or investor presentation itself, so it falls under the general Regulatory Filings category (RNS).
2026-05-07 English
ARS - Scholar Rock Holding Corp (0001727196) (Filer)
Annual Report
2026-04-22 English
DEF 14A - Scholar Rock Holding Corp (0001727196) (Filer)
Proxy Solicitation & Information Statement
2026-04-22 English
8-K - Scholar Rock Holding Corp (0001727196) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes a press release about the resubmission of a biologics license application (BLA) to the FDA and mentions a conference call to discuss this update. There are no detailed financial statements or comprehensive financial analysis present, only an event disclosure and a press release. The document is not an earnings release, annual report, or interim report. It is a regulatory announcement of a material event. Therefore, the filing type is best classified as Regulatory Filings (RNS). The document length is 6832 characters, which is sufficient for a full 8-K but does not contain financial data to qualify as a financial report type. Confidence is high due to the clear identification of the form and content.
2026-03-31 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.